His primary areas of study are Internal medicine, Psychiatry, Depression, Endocrinology and Clinical psychology. His Internal medicine research includes themes of Hamilton Rating Scale for Depression and Risperidone. His work focuses on many connections between Depression and other disciplines, such as Anesthesia, that overlap with his field of interest in Melancholia and Venlafaxine.
Otto Benkert interconnects Amisulpride and Pharmacology in the investigation of issues within Endocrinology. Otto Benkert has included themes like Schizophrenia and Rating scale in his Clinical psychology study. Otto Benkert combines subjects such as History of depression, Bipolar disorder, Research Diagnostic Criteria and Comorbidity with his study of Schizophrenia.
Psychiatry, Internal medicine, Depression, Anesthesia and Endocrinology are his primary areas of study. His biological study deals with issues like Clinical psychology, which deal with fields such as Agoraphobia and Rating scale. His Internal medicine research incorporates elements of Gastroenterology, Psychosis and Amisulpride.
His Research Diagnostic Criteria study, which is part of a larger body of work in Depression, is frequently linked to In patient, bridging the gap between disciplines. The concepts of his Anesthesia study are interwoven with issues in Benzodiazepine, Adverse effect and Sleep in non-human animals, Sleep Stages, Polysomnography. He studied Endocrinology and Pharmacology that intersect with Antidepressant.
His main research concerns Psychiatry, Internal medicine, Erectile dysfunction, Paroxetine and Mirtazapine. His Psychiatry study frequently draws connections to adjacent fields such as Clinical psychology. His work on Psychometrics as part of general Clinical psychology study is frequently linked to Proband, bridging the gap between disciplines.
His Internal medicine research incorporates themes from Endocrinology, Depression, Analeptic, Amisulpride and Polysomnography. His research integrates issues of Venlafaxine, Venlafaxine Hydrochloride and Randomized controlled trial in his study of Mirtazapine. He combines subjects such as Endogenous depression and Flupentixol with his study of Schizophrenia.
The scientist’s investigation covers issues in Psychiatry, Internal medicine, Mirtazapine, Randomized controlled trial and Anesthesia. Otto Benkert is interested in Anxiety, which is a branch of Psychiatry. Many of his studies on Internal medicine apply to Endocrinology as well.
His Mirtazapine research includes elements of Hamilton Rating Scale for Depression and Paroxetine. His studies deal with areas such as Major depressive disorder, Venlafaxine, Venlafaxine Hydrochloride and Randomization as well as Anesthesia. His Antidepressant study is concerned with the field of Depression as a whole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Continuity and Discontinuity of Affective Disorders and Schizophrenia: Results of a Controlled Family Study
W Maier;D Lichtermann;J Minges;J Hallmayer.
Archives of General Psychiatry (1993)
Neuroendocrine response to antipsychotics : Effects of drug type and gender
Gerhard Gründer;Hermann Wetzel;Ralf Schlösser;Ion Anghelescu.
Biological Psychiatry (1999)
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
A Hillert;W Maier;H Wetzel;O Benkert.
Pharmacopsychiatry (1992)
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).
Matthias J. Müller;Petra Marx-Dannigkeit;Ralf Schlösser;Hermann Wetzel.
Journal of Psychiatric Research (1999)
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.
M J Müller;W Rossbach;K Mann;J Röschke.
Pharmacopsychiatry (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
MSD (United States)
Friedrich Schiller University Jena
Max Planck Institute of Psychiatry
University of Tübingen
Charité - University Medicine Berlin
Stanford University
Stanford University
Medical University of Vienna
Heidelberg University
University of Pisa
Copenhagen Business School
London School of Economics and Political Science
City, University of London
University of Manchester
Potsdam Institute for Climate Impact Research
Jinan University
University of California, San Diego
University of Freiburg
International University of Health and Welfare
Universidade de São Paulo
Duke University
Met Office
Oregon State University
Utrecht University
Beth Israel Deaconess Medical Center
Florida State University